News

Thermedical®, a developer of thermal-ablation medical systems to treat ventricular tachycardia (VT), announced that it has received Breakthrough Device Designation from the U.S. Food & Drug Administration (FDA) for its Saline Enhanced...

CathVision ApS, a medical device company developing a novel artificial intelligence therapeutic platform for cardiac electrophysiology procedures, has completed an investment round of a total 13M euro. Both existing and new investors...

Cardiologs, a global leader in artificial intelligence (AI) for cardiac diagnostics, in partnership with the Valley Health System revealed the results of a clinical study that found the Cardiologs' AI-based ECG analysis solution reduces by...

Quail Digital’s wireless headsets help overcome communication difficulties during surgical procedures caused by additional PPE requirements Throughout the COVID-19 pandemic, physicians and their clinical teams are having to adapt to a new...

Affera, Inc., a private medical device company focused on innovative cardiac arrhythmia treatment solutions, announced that its platform was featured prominently in scientific sessions at the Heart Rhythm Society 2020 (HRS) meeting held...

Innovative Health is pleased to announce the availability of three new informational web sessions, designed to help fill the learning gap left by the cancellation of this year’s Heart Rhythm Scientific Sessions. These sessions are intended to...

CardioFocus, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved the next-generation HeartLight® X3 Endoscopic Ablation System for the treatment of drug refractory recurrent symptomatic paroxysmal atrial fibrillation...

Johnson & Johnson Medical Devices Companies* announced that Biosense Webster, Inc.'s THERMOCOOL SMARTTOUCH® SF Ablation Catheter, evaluated in the PRECEPT study for the treatment of persistent atrial fibrillation (AF), resulted in freedom...

Results presented virtually via Heart Rhythm 365 Platform; study met primary effectiveness endpoint of superiority in favor of the hybrid Convergent procedure AtriCure, Inc., a leading innovator in treatments for atrial fibrillation (Afib)...

Boston Scientific announced positive 12-month results from the PINNACLE FLX clinical trial assessing the safety and efficacy of the next-generation WATCHMAN FLX™ Left Atrial Appendage Closure (LAAC) Device for patients with non-valvular...